982
LETTERS
SYNLETT
easily synthesized from allylcyclopentanone 7 in overall approximately
13
30% yield by a 7-step sequence in a highly stereoselective manner.
Acknowledgment. We thank the Korea Science and Engineering
Foundation for financial support (95-0501-06-01-3).
References
1.
2.
3.
4.
5.
(a) Koe, B. K.; Sobin, B. A.; Celmer, W. D. Antibiot. Annu. 1956/
1957, 672. (b) Aizawa, S.; Akutsu, H.; Satomi, T.; Kawabata, S.;
Sasaki, K. J. Antibiot. 1978, 31, 729.
(a) Hudlicky, T.; Natchus, M. G.; Sinai-Zingde, G. J. Org. Chem.
1987, 52, 4641. (b) Hudlicky, T.; Sinai-Zingde, G.; Natchus, M.
G.; Rann, B. C.; Papadopolous, P. Tetrahedron 1987, 43, 5685.
(a) Wu, Y. J.; Burnell, D. J. J. Chem. Soc., Chem. Commun. 1991,
764. (b) Wu, Y. J.; Zhu, Y.-Y.; Burnell, D. J. J. Org. Chem. 1994,
59, 104.
(a) Schore, N. E.; Rowley, E. G. J. Am. Chem. Soc. 1988, 110,
5224. (b) Rowley, E. G.; Schore, N. E. J. Org. Chem. 1992, 57,
6853.
Other synthetic approaches, see : (a) Hua, D. H. J. Am. Chem. Soc.
1986, 108, 3835. (b) Imanishi, T.; Yamashita, M.; Ninbari, F.;
Tanaka, T.; Iwata, C. Chem. Pharm. Bull. 1988, 36, 1371. (c)
Agnel, G.; Negishi, E.-i. J. Am. Chem. Soc. 1991, 113, 7424. (d)
Franck-Neumann, M.; Miesch, M.; Gross, L. Tetrahedron Lett.
1992, 33, 3879. (e) Lange, G. L.; Gottardo, C. J. Org. Chem. 1995,
60, 2183.
6.
(a) Curran, D. P.; Kuo, S.-C. J. Am. Chem. Soc. 1986, 108, 1106.
(b) Schwartz, C. E.; Curran, D. P. J. Am. Chem. Soc. 1990, 112,
9272. (c) Enholm, E. J.; Jia, Z. Tetrahedron Lett. 1996, 37, 1177.
7.
8.
9.
(a) Kim, S.; Kee, I. S.; Lee, S. J. Am. Chem. Soc. 1991, 113, 9882.
(b) Kim, S.; Kee, I. S. Tetrahedron Lett. 1993, 34, 4213.
Lee, H.-Y.; Kim, D.-I.; Kim, S. J. Chem. Soc., Chem. Commun.
1996, 1539.
Kim, S.; Cheong, J. H. Synlett 1997, 947.
10. Treatment of methyl 4,4-dimethyl-2-oxocyclopentanecarboxylate
with allyl bromide and K2CO3 followed by addition of aqueous
KOH afforded 4,4-dimethyl-2-prop-2-enylcyclopentan-1-one (7)
in 70% yield.
stereochemistry of the methyl group would be controlled by steric
interaction between the alkenyl group and hydrogen at the ring junction.
Thus, intermediate 5a would be predominant over intermediate 5b,
yielding the desired stereoisomer as a major product. Furthermore, the
undesired isomer 6 could not undergo cyclization due to the unfavorable
strain form the trans-fused cyclized product.
11. The stereochemistry for hydrogen (2.91ppm) at C1 position of 14
was determined by NOE measurement. Significant NOE was
observed of about 3.07% for hydrogen (2.37ppm) at C8 position.
1H NMR (300 MHz, CDCl3, 14) : δ 5.77 (m, 1H), 4.98 (m, 2H),
2.91 (m, 1H), 2.63 (m, 2H), 2.37 (m, 1H), 2.20-2.01 (m, 3H), 1.95-
1.60 (m, 3H), 1.30-1.15 (m, 3H), 1.04 (s, 3H), 1.01 (s, 3H). 13C
NMR (75 MHz, CDCl3, 14) : δ 220.0, 138.3, 115.0, 51.7, 48.8,
45.1, 43.2, 42.5, 40.1, 35.8, 32.0, 30.2, 28.9, 25.2.
Our synthetic route to the target molecule is straightforward and is
10
shown in Scheme 1. The readily accessible allylcyclopentanone 7 was
12. (a) Piers, E.; Karunaratne, V. J. Chem. Soc., Chem. Commun. 1984,
959. (b) Piers, E.; Karunaratne, V. Can. J. Chem. 1989, 67, 160.
protected and ozonized to afford the aldehyde 8 in 83% yield. Treatment
of 8 with phenylselenoalkyllithium 3 followed by the addition of
aqueous HCl afforded the hydroxyketone 9 in 70% yield. Fortunately,
the formation of the hemiacetal in 9 was not observed. After the
conversion of 9 into N-aziridinylimine 10, when 10 was subjected to the
highly diluted cyclization conditions, an inseparable mixture of the
desired tricyclic compound 11 and the bicyclic compound 12 was
isolated in 84% yield, which existed approximately in a ratio of 6:1
13. A solution of 10 (108 mg, 0.22 mmol) in benzene (44 mL,
0.005M) and a solution of Bu3SnH (139 mg, 0.48 mmol) and
AIBN (11 mg, 0.3 equiv) in benzene (16 mL, 0.03 M) were
degassed for 30 min with nitrogen, respectively. The solution of
Bu3SnH and AIBN was dropwise added to the refluxing benzene
solution of 10 for 30 h by a syringe pump. After being stirred for
additional 2 h, the reaction mixture was concentrated under
reduced pressure and the crude product was subjected to silica gel
column chromatography to give 11 and 12 (38 mg, 6:1, 84%).
Treatment of 11 and 12 (38 mg) with PCC afforded 13 (29 mg,
1
according to H NMR. The stereoselectivity in the first cyclization
turned out to be slightly lower than that we anticipated. After PCC
oxidation of a mixture of 11 and 12, 14 was separated and the
stereochemistry of the substituent was determined by NOE
1
80%) and 14 (4 mg, 11%). H NMR (300 MHz, CDCl3, 13a) : δ
2.67 (m, 1H), 2.36 (m, 1H), 2.27 (d, J=8.6 Hz, 1H), 2.20 (m, 1H),
1.91-1.70 (m, 7H), 1.24 (m, 2H), 1.01 (s, 3H), 1.00 (s, 3H), 0.97
(d, J=7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3, 13a) : δ 225.0,
62.0, 61.3, 56.5, 50.6, 46.5, 45.2, 39.0, 38.8, 34.7, 30.2, 30.1, 29.7,
14.4. IR (NaCl, cm-1) : 2946, 2867, 1737, 1461, 1116. HRMS
calcd. for C14H22O : 206.1671, found 206.1650.
11
experiment. As we anticipated, a 10:1 mixture of 13a and 13b was
1
determined by GC and H NMR analysis, indicating that the second
cyclization was somewhat more stereoselective than the first cyclization.
The conversion of intermediate 13a into the target molecule, dl-
4,12
pentalenene, was previously reported.
The key intermediate 13 was